Table 2.
Biochemical characteristics of the overall sample categorized according to glucose tolerance status.
| Total = 939 individuals | |||
|---|---|---|---|
| Parameter | NGT n = 473 (50.4%) |
Pre-DM n = 250 (26.6%) |
T2DM n = 216 (23%) |
| FPG (mg/dL) | |||
| Mean ± SD | 89.6 ± 6.4 | 107 ± 5.9* | 158.1 ± 68.1∗† |
| Median [IQR] | 90 [86–95] | 105 [102–111] | 135 [111–181] |
| HbA1c (%) | |||
| Mean ± SD | 4.0 ± 0.5 | 4.2 ± 0.8* | 5.9 ± 2.1∗† |
| Median [IQR] | 3.9 [3.7–4.2] | 4.1 [3.9–4.5] | 5.2 [4.4–7.2] |
| HDL-C (mg/dL) | |||
| Mean ± SD | 40.8 ± 12.7 | 39 ± 10.3 | 37.4 ± 10.2* |
| Median [IQR] | 39.2 [31.6–48.5] | 37.1 [31.4–46] | 35.9 [30.5–42.4] |
| Triglycerides (mg/dL) | 184.1 ± 117.2 | 222.3 ± 154.8* | 231.8 ± 301.2* |
| Median [IQR] | 159 [109–219] | 182 [129–266] | 191 [127–264] |
| Fibrinogen (mg/dL) | |||
| Mean ± SD | 369.8 ± 69.1 | 372 ± 69.8 | 385.9 ± 77.8* |
| Median [IQR] | 365 [322–408] | 370 [323–418] | 377 [330–438] |
| hs-CRP (mg/L) | |||
| Mean ± SD | 0.4 ± 0.5 | 0.4 ± 0.7 | 0.5 ± 0.6* |
| Median [IQR] | 0.3 [0.1–0.4] | 0.2 [0.1–0.5] | 0.3 [0.1–0.6] |
Data are means ± standard deviation, median [interquartile range] and percentages; *P value ≤ 0.05 versus NGT; † P value ≤ 0.05 versus pre-DM; NGT: normal glucose tolerance; preDM: pre-diabetes mellitus; T2DM: type 2 diabetes mellitus; FPG: fasting plasma glucose; HbA1c: glycosylated hemoglobin; HDL-C: high-density lipoprotein colesterol; hs-CRP: high sensitivity C-reactive protein.